企業プロフィール
Olink 株価・ニュース・カタリスト
- ティッカー:
- OLK
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for OLK.
企業概要
事業概要
Olink was a proteomics platform company focused on high-throughput protein biomarker analysis before being acquired by Thermo Fisher Scientific.
所在地とセクター分類
Headquartered in Sweden and listed in the United States before acquisition, it sat in life-sciences tools.
ビジネスモデルの特徴
The business was driven by proteomics instrument demand, consumables, and adoption in research and translational science.
バイオ業界での位置付け
Olink was a premium proteomics tools name and is now best viewed through the lens of biotech infrastructure M&A.
今後のカタリスト
- Olink is now largely a Thermo Fisher integration and proteomics-adoption story, with catalysts tied to broader platform usage inside a much bigger life-science footprint. The stock matters mainly if protein-biomarker workflows keep scaling.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。